Media coverage about Hikma Pharmaceuticals (OTCMKTS:HKMPY) has trended somewhat positive on Wednesday, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Hikma Pharmaceuticals earned a media sentiment score of 1.17 on their scale. InfoTrie also assigned media headlines about the company an news buzz score of 10 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company’s share price in the near term.
Shares of Hikma Pharmaceuticals stock remained flat at $$45.44 on Wednesday. Hikma Pharmaceuticals has a 52 week low of $24.60 and a 52 week high of $52.40.
Hikma Pharmaceuticals Company Profile
Featured Article: Market Capitalization
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.